Everus Construction Group, Inc. ECG
Composite 57/100; the shares have moved about 62% annualised. Names that move more contribute more risk for the same amount invested, and our composite reflects how strong the evidence for this one is right now.
Valuation ranks 42/100 — a slight mark against it.
Growth ranks 73/100 — a moderate point in its favour. Balance-sheet strength ranks 64/100 — a moderate point in its favour. Momentum ranks 56/100 — a slight point in its favour.
Valuation ranks 42/100 — a slight mark against it.
What the company does Everus Construction Group (ECG) provides electrical, mechanical, and transmission & distribution contracting services across utilities, renewables, and industrial sectors. Its segments include Electrical & Mechanical (wiring, fire suppression, renewables) and Transmission & Distribution (overhead/underground infrastructure and equipment). The company was spun off from MDU Resources in 2024 and serves public, private, and governmental customers.
Key financials ECG reports strong profitability metrics: ROE 39%, ROA 11.4%, ROCE 30.2%, and net margin 5.7%. Revenue and EPS grew 25.4% and 58.7% year-over-year, respectively. Gross and operating margins stand at 12.4% and 7.5%, with a debt/equity ratio of 0.53 and interest coverage of 17.04.
Stock health Momentum is mixed: -20.10% over 3 months, +16.32% over 6 months, and +50.64% over 12 months. The stock is -36.37% below its 52-week high, with RSI(14) at 28.20, indicating oversold conditions. Sideravia scores ECG 64 overall—average quality but richly valued.
Price vs fair value ECG trades at a PREMIUM of 52.00% versus our fair-value estimate of $52.40 and a discount of 55.35% versus the analyst 12-month target of $169.60. - Fair-value gap reflects high growth expectations amid infrastructure demand (Insider Monkey, 2026-07-27). - Analyst target implies 55% upside, suggesting confidence in margin expansion and renewables tailwinds. - Valuation metrics (P/E 29.75, EV/EBITDA 19.88) remain elevated vs. peers.
Looking forward Forward P/E of 31.25 and strong growth in renewables infrastructure position ECG to benefit from U.S. infrastructure spending. Execution risks include project execution and integration post-spinoff. Monitor order backlog and margin sustainability in high-growth segments.
This is not investment advice. Sideravia provides automated, data-driven analysis for information and education only. Nothing on this page is a personal recommendation or an invitation to buy or sell any security, and it does not consider your objectives or financial situation. Assessments are generated by rules applied uniformly to every covered stock — how our scores work.
Data as of 2026-09-05, compiled from third-party sources; errors and delays are possible and figures are not warranted. Investing puts your capital at risk; past performance does not predict future results. We publish our full track record, including the calls that lost, and our conflicts of interest.